StockData
RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF

Renalytix plc

Financials through Q1 FY2025, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)

Close on Oct 19, 2026

Market cap
$375.75M
P/E (TTM)
–
Dividend yield
–

Renalytix plc revenue by segment

No segment breakdown reported

Renalytix does not break out revenue by segment, region or product in the tagged data of its filings for this period type.